HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 38, 35635-35641, September 20, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/38/35635    most recent M204578200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Velichko, S. Articles by Croze, E. Search for Related Content PubMed PubMed Citation Articles by Velichko, S. Articles by Croze, E. Social Bookmarking                      What's this?

STAT3 Activation by Type I Interferons Is Dependent on Specific Tyrosines Located in the Cytoplasmic Domain of Interferon Receptor Chain 2c
ACTIVATION OF MULTIPLE STATS PROCEEDS THROUGH THE REDUNDANT USAGE OF TWO TYROSINE RESIDUES^*

Sharlene Velichko, T. Charis Wagner, James Turkson^§, Richard Jove^§, and Ed Croze^¶

From the  Department of Immunology, Berlex Biosciences Inc., Richmond, California 94804 and the ^§ Molecular Oncology and Drug Discovery Programs, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612

Human type I interferons (IFNs) play an important role in the regulation of antiviral defense mechanisms, immunomodulatory activities, and growth control. Recent efforts have demonstrated the importance of IFNs in the activation of signal transducers and activators of transcription (STATs). The role of STAT1 and STAT2 in IFN-dependent JAK-STAT signaling is well established; however, the role of STAT3 and its activation by IFNs remains unclear. Understanding the IFN-dependent regulation of STAT3 is of increasing interest because recent studies have demonstrated that STAT3 may play a role in cancer. Studies have revealed that STAT3 is constitutively active in a number of cancer cell lines and that overexpression of an active form of STAT3 transforms normal fibroblasts. Therefore, STAT3 exhibits properties indicative of known oncogenes. In this report, we define the role of the type I IFN receptor in STAT3 activation and identify for the first time tyrosine residues present in the cytoplasmic domain of IFNAR2c that are critical for STAT3 activation. The regulation of STAT3 activation by IFNs was measured in a human lung fibrosarcoma cell line lacking IFNAR2c but stably expressing various IFNAR2c tyrosine mutants. We show here that in addition to IFN-dependent tyrosine phosphorylation of STAT3, activation using a STAT3-dependent electrophoretic mobility shift assay and a STAT3-specific reporter can also be demonstrated. Furthermore, we demonstrate that type I IFN-dependent activation of STAT3 proceeds through a novel mechanism that is dependent on two tyrosines, Tyr³³⁷ and Tyr⁵¹², present in IFNAR2c and contained within a conserved six-amino acid residue motif, GxGYxM. Surprisingly, both tyrosines were previously shown to be required for type I IFN-dependent STAT1 and STAT2 activation. Our results reveal that type I IFNs activate multiple STATs via the overlapping usage of two tyrosine residues located in the cytoplasmic domain of IFNAR2c.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				W. Zhao, C. Lee, R. Piganis, C. Plumlee, N. de Weerd, P. J. Hertzog, and C. Schindler A Conserved IFN-{alpha} Receptor Tyrosine Motif Directs the Biological Response to Type I IFNs J. Immunol., April 15, 2008; 180(8): 5483 - 5489. [Abstract] [Full Text] [PDF]

				N. Molnarfi, N. Hyka-Nouspikel, L. Gruaz, J.-M. Dayer, and D. Burger The Production of IL-1 Receptor Antagonist in IFN-{beta}-Stimulated Human Monocytes Depends on the Activation of Phosphatidylinositol 3-Kinase but Not of STAT1 J. Immunol., March 1, 2005; 174(5): 2974 - 2980. [Abstract] [Full Text] [PDF]

				B. Ahr, M. Denizot, V. Robert-Hebmann, A. Brelot, and M. Biard-Piechaczyk Identification of the Cytoplasmic Domains of CXCR4 Involved in Jak2 and STAT3 Phosphorylation J. Biol. Chem., February 25, 2005; 280(8): 6692 - 6700. [Abstract] [Full Text] [PDF]

				M. Yeh, N. M. Gharavi, J. Choi, X. Hsieh, E. Reed, K. P. Mouillesseaux, A. L. Cole, S. T. Reddy, and J. A. Berliner Oxidized Phospholipids Increase Interleukin 8 (IL-8) Synthesis by Activation of the c-src/Signal Transducers and Activators of Transcription (STAT)3 Pathway J. Biol. Chem., July 16, 2004; 279(29): 30175 - 30181. [Abstract] [Full Text] [PDF]

				J-L Yang, X-J Qu, P J Russell, and D Goldstein Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon {alpha} Gut, January 1, 2004; 53(1): 123 - 129. [Abstract] [Full Text] [PDF]

				H. Palosaari, J.-P. Parisien, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath STAT Protein Interference and Suppression of Cytokine Signal Transduction by Measles Virus V Protein J. Virol., July 1, 2003; 77(13): 7635 - 7644. [Abstract] [Full Text] [PDF]

				C. M. Ulane, J. J. Rodriguez, J.-P. Parisien, and C. M. Horvath STAT3 Ubiquitylation and Degradation by Mumps Virus Suppress Cytokine and Oncogene Signaling J. Virol., June 1, 2003; 77(11): 6385 - 6393. [Abstract] [Full Text] [PDF]